Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Prepaid Assets (2019 - 2025)

Harmony Biosciences Holdings' Prepaid Assets history spans 7 years, with the latest figure at $13.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 66.43% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $13.5 million, up 66.43%, while the annual FY2025 figure was $13.5 million, 66.43% up from the prior year.
  • Prepaid Assets for Q4 2025 was $13.5 million at Harmony Biosciences Holdings, down from $23.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.3 million in Q3 2025 and bottomed at $1.5 million in Q1 2021.
  • The 5-year median for Prepaid Assets is $10.3 million (2021), against an average of $10.5 million.
  • The largest YoY upside for Prepaid Assets was 594.48% in 2022 against a maximum downside of 58.05% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $3.2 million in 2021, then soared by 190.46% to $9.3 million in 2022, then tumbled by 40.76% to $5.5 million in 2023, then surged by 46.67% to $8.1 million in 2024, then skyrocketed by 66.43% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Prepaid Assets are $13.5 million (Q4 2025), $23.3 million (Q3 2025), and $18.4 million (Q2 2025).